Proteasome inhibitor Aclacinomycin A, Purity ≥98%

Cat. No.: X24-07-ZQ797

Proteasome inhibitor Aclacinomycin A, Purity ≥98%

Synonym: 57576-44-0; Proteasome inhibitor; Jaclacin; Aclarubicin

  • MDL: MFCD00866250
  • CAS Number: 57576-44-0
  • Compound CID: 451415
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Aclacinomycin A interferes with the proteasome’s ability to degrade proteins, thereby disrupting cellular processes in cancer cells, particularly multiple myeloma.
Molecular Weight
811.87
Molecular Formula
C42H53NO15
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
Aclacinomycin A is employed in studies to understand its inhibitory effects on proteasome activity, providing insights into cancer therapies.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0